medigraphic.com
Colegio de Medicina Interna de México.

2020, Number 1

<< Back Next >>

Med Int Mex 2020; 36 (1)

Function of vitamin D in prevention of diseases

Gómez-Piña JJ

Language: Spanish
References: 40
Page: 68-76
PDF size: 239.55 Kb.


ABSTRACT

Day by day, vitamin D becomes more important, not only in the field of nutrition, but in several fields, being immunology one of the most important, because it is related to some regulatory mechanisms. Because the synthesis of vitamin D starts from exposure to UV rays, it is extremely important to maintain adequate serum levels of vitamin D and avoid predisposition to several diseases; however, when this is not possible, due to chronic renal disease or prolonged stays in shaded areas, will be required vitamin D supplementation. This vitamin D supplementation has been associated with a decreased risk of certain diseases, as well as an improvement in their prognosis, such as diabetes mellitus type 1, lupus, rheumatoid arthritis, vascular diseases such as hypertension, peripheral arterial disease, cerebral vascular event, as well as dementias, headaches, multiple sclerosis, myasthenia gravis, and even infections; so, their role is no longer limited to calcium and phosphorus metabolism, but nowadays it is related to multiple systems described and missing to be described.


REFERENCES

  1. Bouillon R. Vitamin D: from photosynthesis, metabolism, and action to clinical application. In: Endocrinology, LJ DeGroot, JL Jameson, editors. Philadelphia: WB Saunders, 2001;1009-1028.

  2. DeLuca HF. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 2004;80(6):1689S- 1696S.

  3. Hruska KA. Hyperphosphatemia and hypophosphatemia. In: Primer on the metabolic bone diseases and disorders of mineral metabolism. MJ Favus, editor. 6th ed. Washington DC: American Society for Bone and Mineral Research, 2006:233-242.

  4. Bouillon R, Carmeliet G, Verlinden L, van Etten E, Verstuyf A, Luderer HF, Lieben L, Mathieu C, Demay M. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 2008;29:726-776. doi: 10.1210/er.2008-0004.

  5. Myszka M, Klinger M. The immunomodulatory role of Vitamin D, Departamento de Nefrología y Medicina de Trasplantes de la Universidad de Ciencias Médicas de Wroclaw, Postepy Hig Med Dosw (online), 2014;68.

  6. Chen S, Sims GP, Chen XX, Gu YY, Chen S, Lipsky PE. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol 2007;179:1634-1647. DOI: 10.4049/jimmunol.179.3.1634.

  7. Ponsonby AL, McMichael A, van der Mei I. Ultraviolet radiation and autoimmune disease: insights from epidemiological research. Toxicology 2002 Dec 27;181-182:71- 78. DOI: 10.1016/s0300-483x(02)00257-3.

  8. Tan X, Wen X, Liu Y. Paricalcitol inhibits renal inflammation by promoting vitamin D receptor-mediated sequestration of NF-kappaB signaling. J Am Soc Nephrol 2008;19:1741- 1752. doi: 10.1681/ASN.2007060666.

  9. Kamen D, Aranow C. Vitamin D in systemic lupus erythematosus. Curr Opin Rheumatol 2008;20:532-7. doi: 10.1097/ BOR.0b013e32830a991b.

  10. Urry Z, Chambers ES, Xystrakis E, Dimeloe S, Richards DF, Gabrysova L, Christensen J, Gupta A, Saglani S, Bush A, O’Garra A, Brown Z, Hawrylowicz CM. The role of 1α,25- dihydroxyvitamin D3 and cytokines in the promotion of distinct Foxp3+ and IL-10+ CD4+ T cells. Eur J Immunol 2012;42:2697-2708. doi: 10.1002/eji.201242370.

  11. Bluestone JA, Tang Q. How do CD4+CD25+ regulatory T cells control autoimmunity? Curr Opin Immunol 2005;17:638- 642. DOI: 10.1016/j.coi.2005.09.002.

  12. Smolders J, Thewissen M, Peelen E, et al. Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis. PLoS ONE 2009;4:e6635. doi: 10.1371/journal.pone.0006635.

  13. Wang TJ, Zhang F, Richards JB, et al. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 2010;376(9736):180-8. doi: 10.1016/ S0140-6736(10)60588-0.

  14. Welsh J. Targets of vitamin D receptor signaling in the mammary gland. J Bone Miner Res 2007;22:V86-90. doi: 10.1359/jbmr.07s204.

  15. Bailey R, Cooper JD, Zeitels L, et al. Association of the vitamin D metabolism gene CYP27B1 with type 1 diabetes. Diabetes 2007;56(10):2616-21. DOI: 10.2337/db07-0652.

  16. Sawcer S, Hellenthal G, Pirinen M, et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011;476(7359):214-9. doi: 10.1038/nature10251.

  17. Sørensen IM, Joner G, Jenum PA, Eskild A, Torjesen PA, Stene LC. Maternal serum levels of 25-hydroxy-vitamin D during pregnancy and risk of type 1 diabetes in the offspring. Diabetes 2012;61:175-8. doi: 10.2337/db11-0875.

  18. Williams PF, Caterson ID, Cooney GJ, Zilkens RR, Turtle JR. High affinity insulin binding and insulin receptor-effector coupling: modulation by Ca2+. Cell Calcium 1990;11:547- 556. DOI: 10.1016/0143-4160(90)90031-o.

  19. Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and metaanalysis. J Clin Endocrinol Metab 2007;92:2017- 29. DOI: 10.1210/jc.2007-0298.

  20. Kaur H, Donaghue KC, Chan AK, et al. Vitamin D deficiency is associated with retinopathy in children and adolescents with type 1 diabetes. Diabetes Care 2011;34(6):1400-2. doi: 10.2337/dc11-0103.

  21. Adorini L. Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting autoimmune diabetes. Ann NY Acad Sci 2003;987:258-61. DOI: 10.1111/j.1749-6632.2003.tb06057.x.

  22. Giulietti A, Gysemans C, Stoffels K, van Etten E, Decallonne B, Overbergh L, et al. Vitamin D deficiency in early life accelerates type 1 diabetes in nonobese diabetic mice. Diabetologia 2004;47:451-62. doi: 10.1007/s00125-004-1329-3.

  23. Minambres I, Quesada J, Hernandez J, Rodriguez J, Leiva A, Perez A. Vitamin D concentrations in familial combined hyperlipidemia: effects of lipid lowering treatment. Diabetol Metab Syndr 2014;6:7.

  24. McGreevy C, Williams D. New insights about vitamin D and cardiovascular disease: a narrative review. Ann Intern Med. 2011;155:820-6. doi: 10.7326/0003-4819-155-12- 201112200-00004.

  25. Müller K, Haahr PM, Diamant M, Rieneck K, Kharazmi A, Bendtzen K. 1,25-Dihydroxyvitamin D3 inhibits cytokine production by human blood monocytes at the post-transcriptional level. Cytokine 1992;4:506-12. DOI: 10.1016/1043-4666(92)90012-g.

  26. Von Hurst PR, Stonehouse W, Coad J. Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient — a randomized, placebo-controlled trial. Br J Nutr 2010;103:549-55. doi: 10.1017/S0007114509992017.

  27. Shah SM, Carey IM, Harris T, DeWilde S, Cook DG. Calcium supplementation, cardiovascular disease and mortality in older women. Pharmacoepidemiol Drug Saf 2010;19:59- 64. doi: 10.1002/pds.1859.

  28. Zehnder D, Quinkler M, Eardley KS, Bland R, et al. Reduction of the vitamin D hormonal system in kidney disease is associated with increased renal inflammation. Kidney Int 2008;74:1343-1353. doi:10.1038/ki.2008.453.

  29. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008;117:503-11. doi: 10.1161/ CIRCULATIONAHA.107.706127.

  30. Autier P, Gandini S. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med 2007;167:1730-7. DOI: 10.1001/archinte. 167.16.1730.

  31. Soni M, Kos K, Lang IA, Jones K, Melzer D, Llewellyn DJ. Vitamin D and cognitive function. Scand J Clin Lab Invest Suppl. 2012;243:79-82. doi: 10.3109/00365513.2012.681969.

  32. Badireddi S, Bercher AJ, et al. Vitamin D deficiency in patients with neuromuscular diseases with chronic respiratory failure. J Parenter Enteral Nutr. 2014;38:602-607. doi: 10.1177/0148607113491291.

  33. Visser M, Deeg D, Lips P. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab 2003;88:5766-72. DOI: 10.1210/jc.2003-030604.

  34. Nahla Alshaikh et al. Vitamin D in corticosteroid-naïve and corticosteroid treated Duchenne muscular dystrophy: what dose achieves optimal 25(OH) vitamin D levels? Arch Dis Child 2016;101:957-961. doi: 10.1136/archdischild- 2015-308825. E.

  35. Sun Q, Pan A, Hu F, Manson J, Rexrode KM. 25-Hydroxyvitamin D levels and the risk of stroke: a prospective study and meta-analysis. Stroke 2012;43:1470-7. doi: 10.1161/ STROKEAHA.111.636910.

  36. Ando M, Shibuya A, Tsuchiya K, Akiba T, Nitta K. Reduced expression of Toll-like receptor 4 contributes to impaired cytokine response of monocytes in uremic patients. Kidney Int 2006;70:358-362. DOI: 10.1038/sj.ki.5001548.

  37. Youssef DM, Elshal AS, et al. Assessment of immune status in relation to vitamin D levels in children on regular hemodialysis. Saudi J Kidney Dis Transpl 2012;23(2):267-273.

  38. Teng M, Wolf M, Ofsthun MN, Lazarus JM, Hernan MA, Camargo CA Jr, Thadhani R. Activated injectable vitamin D and hemodialysis survival: a historical cohort study. J Am Soc Nephrol 2005;16:1115-1125. DOI: 10.1681/ ASN.2004070573.

  39. Liu PT, Stenger S, Li H, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006;311(5768):1770-3. DOI: 10.1126/science.1123933.

  40. Brockman-Schneider R, Pickles R, Gern J. Effects of vitamin D on airway epithelial cell morphology and rhinovirus replication. PLoS ONE 2014;9:e86755.




2020     |     www.medigraphic.com